Tánaiste to meet US Pharmaceutical Representatives
- Published on: 16 July 2025
- Last updated on: 18 July 2025
Today (16 July), the Tánaiste and Minister for Foreign Affairs and Trade, Simon Harris, will meet senior representatives from the pharmaceutical sector based in the United States.
The online meeting comes at a critical juncture in EU-US trade talks and amid the ongoing US Section 232 investigation into the pharmaceutical sector. An important component of Ireland’s economic relationship with the United States includes significant, mutually beneficial trade and investment partnerships in the pharmaceutical sector.
Speaking before the meeting the Tánaiste said:
“The economic partnership between Ireland and the US, and the EU and the US in the pharmaceutical sector, is critically important. Trade and investment in this sector is mutually beneficial. Section 232 investigations are focused on national security issues; the integrated supply chain in pharma products between the EU, including Ireland and the US, supports rather than threatens our collective transatlantic economic security.
“Fundamentally, governments and businesses alike have an interest in mutually beneficial transatlantic trade and investment, in supporting jobs on both sides of the Atlantic, and in pursuing negotiated solutions to trade and economic disputes. This is at the core of my ongoing outreach, both to the US government and to representatives of key economic sectors both domestically and in the US.”